Paper2155997
Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant.
Boursnell ME and 9 others. J Gen Virol, 1990. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant. Papers, record 2155997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2155997
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Insertion of the fusion gene from Newcastle disease virus into a non-essential region in the terminal repeats of fowlpox virus and demonstration of protective immunity induced by the recombinant.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cloning, Molecular | Major topic |
| DNA Transposable Elements | Major topic |
| Fowlpox virus | Major topic |
| Genes, Viral | Major topic |
| Immunity | Major topic |
| Newcastle disease virus | Major topic |
| Repetitive Sequences, Nucleic Acid | Major topic |
| Animals | |
| Blotting, Western | |
| Cell Line | |
| Chickens | |
| Enzyme-Linked Immunosorbent Assay | |
| Genetic Vectors | |
| Hemagglutination Inhibition Tests | |
| Plasmids | |
| Restriction Mapping |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41348231 | Adaptive immune response of poultry to Newcastle disease vaccines. | Arch Virol | 2025 | https://conductscience.org/library/papers/41348231 | PubMed |
| 38801571 | Characterization of Fowlpox Virus. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/38801571 | PubMed |
| 36435802 | Current situation and future direction of Newcastle disease vaccines. | Vet Res | 2022 | https://conductscience.org/library/papers/36435802 | PubMed |
| 33094109 | Rapid Development of an Effective Newcastle Disease Virus Vaccine Candidate by Attenuation of a Genotype VII Velogenic Isolate Using a Simple Infectious Cloning System. | Front Vet Sci | 2020 | https://conductscience.org/library/papers/33094109 | PubMed |
| 33009986 | Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10. | Virus Genes | 2020 | https://conductscience.org/library/papers/33009986 | PubMed |
| 28024856 | Newcastle disease vaccines-A solved problem or a continuous challenge? | Vet Microbiol | 2017 | https://conductscience.org/library/papers/28024856 | PubMed |
| 19297615 | Potential use of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed in Rachiplusia nu larvae as an immunogen for chickens. | Clin Vaccine Immunol | 2009 | https://conductscience.org/library/papers/19297615 | PubMed |
| 18716451 | Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins. | J Vet Sci | 2008 | https://conductscience.org/library/papers/18716451 | PubMed |
| 8876137 | Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8876137 | PubMed |
| 8394070 | Role of the TK+ phenotype in the stability of pigeonpox virus recombinant. | Arch Virol | 1993 | https://conductscience.org/library/papers/8394070 | PubMed |
| 8388488 | Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens. | J Virol | 1993 | https://conductscience.org/library/papers/8388488 | PubMed |
| 8270268 | Recombinant fowlpox virus vaccines for poultry. | Immunol Cell Biol | 1993 | https://conductscience.org/library/papers/8270268 | PubMed |
| 7889464 | Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter. | Can J Vet Res | 1994 | https://conductscience.org/library/papers/7889464 | PubMed |
| 1714521 | Endogenous interferon specifically regulates Newcastle disease virus-induced cytokine gene expression in mouse macrophages. | J Virol | 1991 | https://conductscience.org/library/papers/1714521 | PubMed |
| 1659797 | A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. | Arch Virol | 1991 | https://conductscience.org/library/papers/1659797 | PubMed |
| 1646592 | Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge. | Arch Virol | 1991 | https://conductscience.org/library/papers/1646592 | PubMed |
| 1319788 | Recent advances in avian virology. | Br Vet J | 1992 | https://conductscience.org/library/papers/1319788 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2155997
GET https://conductscience.org/api/papers/v1/2155997/authors